Biological E ties up with Canadian firm Providence for mRNA Covid vaccine

The vaccine, named PTX-COVID19-B, is under development in Canada; the deal assumes significance as this gives India access to the mRNA tech

Hyderabad-based Biological E tied up with Calgary-based Providence Therapeutics to manufacture its mRNA technology-based Covid-19 vaccine and do clinical trials in India. The deal assumes significance as this gives India access to the mRNA technology.

The vaccine, named PTX-COVID19-B, is under development in Canada at the moment. Providence announced data from the phase 1 trials in May and will begin the phase 2 trials soon.

“The mRNA platform has emerged as the front runner in delivering the first vaccines for emergency use to combat the COVID-19 pandemic. Biological E. is very pleased to be able to work with Providence on